Cargando…

Defining a novel subset of CD1d‐dependent type II natural killer T cells using natural killer cell‐associated markers

Natural killer T (NKT) cells are αβ T cell receptor (TCR) expressing innate‐like T cells that display natural killer (NK) cell markers. Based on TCR characteristics, they are divided into two groups restricted to the MHC class I‐like molecule CD1d. Type I NKT cells, most extensively studied, are ide...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Avadhesh Kumar, Rhost, Sara, Löfbom, Linda, Cardell, Susanna L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851763/
https://www.ncbi.nlm.nih.gov/pubmed/31141185
http://dx.doi.org/10.1111/sji.12794
_version_ 1783469681208721408
author Singh, Avadhesh Kumar
Rhost, Sara
Löfbom, Linda
Cardell, Susanna L.
author_facet Singh, Avadhesh Kumar
Rhost, Sara
Löfbom, Linda
Cardell, Susanna L.
author_sort Singh, Avadhesh Kumar
collection PubMed
description Natural killer T (NKT) cells are αβ T cell receptor (TCR) expressing innate‐like T cells that display natural killer (NK) cell markers. Based on TCR characteristics, they are divided into two groups restricted to the MHC class I‐like molecule CD1d. Type I NKT cells, most extensively studied, are identified by a semi‐invariant Vα14‐Jα18 (mouse, Vα24‐Jα18 in humans) TCR reactive to the prototypic ligand α‐galactosylceramide presented on CD1d. In contrast, type II NKT cells display diverse TCR reacting to different CD1d‐presented ligands. There are no reagents that identify all type II NKT cells, limiting their exploration. Here, we searched for novel type II NKT cells by comparing Jα18(−/−)MHCII(−/−) mice that harbour type II but not type I NKT cells, and CD1d(−/−)MHCII(−/−) mice, lacking all NKT cells. We identified significantly larger populations of CD4(+) and CD4(−)CD8(−) (double negative, DN) TCRβ(+) cells expressing NKG2D or NKG2A/C/E in Jα18(−/−)MHCII(−/−) mice compared with CD1d(−/−)MHCII(−/−) mice, suggesting that 30%‐50% of these cells were type II NKT cells. They expressed CD122, NK1.1, CXCR3 and intermediate/low levels of CD45RB. Further, the CD4(+) subset was CD69(+), while the DN cells were CD49b(+) and CD62L(+). Both subsets expressed the NKT cell‐associated promyelocytic leukaemia zinc finger (PLZF) transcription factor and Tbet, while fewer cells expressed RORγt. NKG2D(+) CD4(+) and DN populations were producers of IFN‐γ, but rarely IL‐4 and IL‐17. Taken together, we identify a novel subset of primary CD4(+) and DN type II NKT cells that expresses NKG2 receptors have typical NKT cell phenotypes and a TH1‐like cytokine production.
format Online
Article
Text
id pubmed-6851763
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-68517632019-11-18 Defining a novel subset of CD1d‐dependent type II natural killer T cells using natural killer cell‐associated markers Singh, Avadhesh Kumar Rhost, Sara Löfbom, Linda Cardell, Susanna L. Scand J Immunol Experimental Immunology Natural killer T (NKT) cells are αβ T cell receptor (TCR) expressing innate‐like T cells that display natural killer (NK) cell markers. Based on TCR characteristics, they are divided into two groups restricted to the MHC class I‐like molecule CD1d. Type I NKT cells, most extensively studied, are identified by a semi‐invariant Vα14‐Jα18 (mouse, Vα24‐Jα18 in humans) TCR reactive to the prototypic ligand α‐galactosylceramide presented on CD1d. In contrast, type II NKT cells display diverse TCR reacting to different CD1d‐presented ligands. There are no reagents that identify all type II NKT cells, limiting their exploration. Here, we searched for novel type II NKT cells by comparing Jα18(−/−)MHCII(−/−) mice that harbour type II but not type I NKT cells, and CD1d(−/−)MHCII(−/−) mice, lacking all NKT cells. We identified significantly larger populations of CD4(+) and CD4(−)CD8(−) (double negative, DN) TCRβ(+) cells expressing NKG2D or NKG2A/C/E in Jα18(−/−)MHCII(−/−) mice compared with CD1d(−/−)MHCII(−/−) mice, suggesting that 30%‐50% of these cells were type II NKT cells. They expressed CD122, NK1.1, CXCR3 and intermediate/low levels of CD45RB. Further, the CD4(+) subset was CD69(+), while the DN cells were CD49b(+) and CD62L(+). Both subsets expressed the NKT cell‐associated promyelocytic leukaemia zinc finger (PLZF) transcription factor and Tbet, while fewer cells expressed RORγt. NKG2D(+) CD4(+) and DN populations were producers of IFN‐γ, but rarely IL‐4 and IL‐17. Taken together, we identify a novel subset of primary CD4(+) and DN type II NKT cells that expresses NKG2 receptors have typical NKT cell phenotypes and a TH1‐like cytokine production. John Wiley and Sons Inc. 2019-06-26 2019-09 /pmc/articles/PMC6851763/ /pubmed/31141185 http://dx.doi.org/10.1111/sji.12794 Text en © 2019 The Authors. Scandinavian Journal of Immunology published by John Wiley & Sons Ltd on behalf of The Foundation for the Scandinavian Journal of Immunology This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Experimental Immunology
Singh, Avadhesh Kumar
Rhost, Sara
Löfbom, Linda
Cardell, Susanna L.
Defining a novel subset of CD1d‐dependent type II natural killer T cells using natural killer cell‐associated markers
title Defining a novel subset of CD1d‐dependent type II natural killer T cells using natural killer cell‐associated markers
title_full Defining a novel subset of CD1d‐dependent type II natural killer T cells using natural killer cell‐associated markers
title_fullStr Defining a novel subset of CD1d‐dependent type II natural killer T cells using natural killer cell‐associated markers
title_full_unstemmed Defining a novel subset of CD1d‐dependent type II natural killer T cells using natural killer cell‐associated markers
title_short Defining a novel subset of CD1d‐dependent type II natural killer T cells using natural killer cell‐associated markers
title_sort defining a novel subset of cd1d‐dependent type ii natural killer t cells using natural killer cell‐associated markers
topic Experimental Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851763/
https://www.ncbi.nlm.nih.gov/pubmed/31141185
http://dx.doi.org/10.1111/sji.12794
work_keys_str_mv AT singhavadheshkumar defininganovelsubsetofcd1ddependenttypeiinaturalkillertcellsusingnaturalkillercellassociatedmarkers
AT rhostsara defininganovelsubsetofcd1ddependenttypeiinaturalkillertcellsusingnaturalkillercellassociatedmarkers
AT lofbomlinda defininganovelsubsetofcd1ddependenttypeiinaturalkillertcellsusingnaturalkillercellassociatedmarkers
AT cardellsusannal defininganovelsubsetofcd1ddependenttypeiinaturalkillertcellsusingnaturalkillercellassociatedmarkers